Relay Therapeutics

Relay Therapeutics is a clinical-stage precision-medicine company in Cambridge, Massachusetts that discovers and develops small-molecule therapeutics for cancer and genetic disease. Its proprietary Dynamo platform combines computational and experimental approaches — motion-based drug discovery, protein-motion simulation, structural biology, and biophysics — to drug targets that have historically been difficult to reach. The company advances a pipeline of oncology and precision-medicine candidates. Relay Therapeutics was surfaced as a portfolio company of SoftBank Vision Fund and added to the API Evangelist network. As a biotechnology / drug-discovery company it publishes no public developer API, SDK, or webhook surface; this profile captures its corporate identity and web properties.

Relay Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Drug Discovery, and Precision Medicine.

Relay Therapeutics’ developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealth TechBiotechnologyDrug DiscoveryPrecision MedicineOncologyLife SciencesPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/relay-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Relay Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Other 1

Properties that don't map to a standard resource type

Pipeline
Pipeline

Source (apis.yml)

apis.yml Raw ↑ 
aid: relay-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/relay-therapeutics.png
name: Relay Therapeutics
description: Relay Therapeutics is a clinical-stage precision-medicine company in Cambridge, Massachusetts that discovers
  and develops small-molecule therapeutics for cancer and genetic disease. Its proprietary Dynamo platform combines computational
  and experimental approaches — motion-based drug discovery, protein-motion simulation, structural biology, and biophysics
  — to drug targets that have historically been difficult to reach. The company advances a pipeline of oncology and precision-medicine
  candidates. Relay Therapeutics was surfaced as a portfolio company of SoftBank Vision Fund and added to the API Evangelist
  network. As a biotechnology / drug-discovery company it publishes no public developer API, SDK, or webhook surface; this
  profile captures its corporate identity and web properties.
url: https://raw.githubusercontent.com/api-evangelist/relay-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Health Tech
- Biotechnology
- Drug Discovery
- Precision Medicine
- Oncology
- Life Sciences
- Pharmaceuticals
apis: []
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1
common:
- type: DomainSecurity
  url: security/relay-therapeutics-domain-security.yml
- type: Website
  url: https://relaytx.com
- type: Blog
  url: https://ir.relaytx.com/news-events/press-releases
- type: Pipeline
  url: https://relaytx.com/pipeline/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io